Cabozantinib demonstrates significant improvement in PFS by BICR in advanced neuroendocrine tumours

Advancements in paediatric Acute lymphoblastic leukemia management

Cemiplimab monotherapy could be a new treatment option for first line advanced NSCLC patients

ESMO 2024: Best practice in HRRm testing in patients with metastatic prostate cancer

ESMO 2024: Optimising the personalisation of prostate cancer treatment

Understanding patient factors and barriers in oncology treatment

Association of adult attachment with delays in accessing specialist care in women with ovarian cancer

Managing 'fear of recurrence' of cancer patients

Multiple myeloma In Rwanda: The need for further research

Addressing the rise of multiple myeloma in Rwanda

Durvalumab, gemcitabine and cisplatin continue to show clinically meaningful long-term survival in biliary tract cancer patients

GIST tumours and soft tissue sarcomas